All News

Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer

COLUMBIA, Md., Oct. 06, 2016 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has appointed R. Alberto Avendano, M.D., as the Company’s Chief Medical Officer. Dr. Avendano brings to Osiris his expertise in medical education and communication, academic and industry clinical research, pharmacovigilance and regulatory affairs.  In his role as Chief Medical Officer, Dr. Avendano will manage and oversee the […]

Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer

COLUMBIA, Md., Oct. 06, 2016 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has appointed R. Alberto Avendano, M.D., as the Company’s Chief Medical Officer. Dr. Avendano brings to Osiris his expertise in medical education and communication, academic and industry clinical research, pharmacovigilance and regulatory affairs.  In his role as Chief Medical Officer, Dr. Avendano will manage and oversee the […]

Polymers enable lighter medical devices

October 5, 2016 Alpharetta, Georgia – Solvay’s medical grade KetaSpire polyetheretherketone (PEEK) and AvaSpire polyaryletherketone (PAEK) polymers enabled medical device pioneer, Shanghai Reach Medical Instrument Co., to develop a lighter, more ergonomic and highly cost-effective kit of reusable instruments for spinal surgeries. “For decades, metal was the material of choice for medical instruments because conventional […]

Polymers enable lighter medical devices

October 5, 2016 Alpharetta, Georgia – Solvay’s medical grade KetaSpire polyetheretherketone (PEEK) and AvaSpire polyaryletherketone (PAEK) polymers enabled medical device pioneer, Shanghai Reach Medical Instrument Co., to develop a lighter, more ergonomic and highly cost-effective kit of reusable instruments for spinal surgeries. “For decades, metal was the material of choice for medical instruments because conventional […]

Nanoparticle injections may be future of osteoarthritis treatment

By Jim Dryden Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries. Over-the-counter painkillers, such as anti-inflammatory drugs, help reduce pain but do not stop unrelenting cartilage destruction. Consequently, pain related to the condition only gets […]

Medicrea Announces 2016 Third-Quarter Sales

October 06, 2016 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the development and manufacture of personalized analytical services and implant solutions for the treatment of complex spinal conditions, announced its sales for the 3rd quarter ending September 30, 2016. € millions 2015 2016 Δ Half-year 1 […]

New Extremity Products are Driving Growth for Arthrosurface

FRANKLIN, Mass., Oct. 6, 2016 /PRNewswire/ — Arthrosurface® announced today that at the September 27, 2016 American Society for Podiatric Surgery (ASPS) meeting in Baltimore, Maryland, the new CheckMATE® 3.0 Fusion Plate was launched for end stage toe arthritis. One study showed that 35%-60% of the population over 65 years old has osteoarthritis of the big toe, making this a common problem. The CheckMATE® plate […]

Histogenics Corporation Announces Addition of Dr. Lawrence Bonassar of Cornell University to Its Scientific Advisory Board

WALTHAM, Mass., Oct. 06, 2016 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced today the addition of Professor Lawrence Bonassar to its Scientific Advisory Board (SAB).  The SAB’s mission is to provide strategic scientific and technical oversight as Histogenics brings NeoCart through its ongoing Phase 3 clinical trial, and seeks to […]

Xtant Medical Announces the Appointment of Carl O’Connell as President

BELGRADE, Mont., Oct. 06, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the appointment of Carl O’Connell as President, reporting to the CEO effective October 6, 2016. Mr. O’Connell will lead all commercial efforts by providing the vision, leadership, […]

K2M Expands 3D-Printed MIS CASCADIA™ Lateral Interbody System Featuring Lamellar 3D Titanium Technology™

LEESBURG, Va., Oct. 06, 2016 (GLOBE NEWSWIRE) — K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1